Navigation Links
SAFE IN COMMON Launches Global Injection Safety Website
Date:11/5/2010

LEWISBERRY, Pa., Nov. 5, 2010 /PRNewswire/ -- SAFE IN COMMON, an online community of  healthcare workers, educators, patients, community leaders and individuals, today announced the launch of its website dedicated to raising awareness of global injection safety challenges.

SAFE IN COMMON's launch coincides with the 10th anniversary of the passage of the Needlestick Safety and Prevention Act, which mandates the use of safety engineered medical devices, (SEMDs), within U.S. healthcare facilities to protect healthcare workers and patients from the risk of needlestick injuries. Despite this legislation and its enforcement by OSHA, healthcare workers continue to remain at risk of harm.  For example, reports in the U.S. indicate that currently available safety syringes are not providing adequate levels of protection.  In fact, reported needlestick injuries in Massachusetts have not fallen since 2002, and safety products are responsible for the majority of those injuries.

While steps have been taken in the U.S. and Europe to mandate the use of SEMDs, the harm caused by unsafe injection practices represents a global humanitarian challenge. According to the World Health Organization (WHO), there are more than 1.3 million needlestick related deaths worldwide each year.

"As a former nurse, I have first hand experience with the physical and emotional dangers of a needlestick injury. However, the problems and risks associated with needlestick injuries are real and affect the lives of millions of people around the world, not just those in the healthcare field," commented Dr. Mary Foley, Associate Director, Center for Nursing Research and Innovation. "Much has been accomplished since the signing of the Needlestick Safety and Prevention Act of 2000, but the safety laws and policies currently in place are poorly enforced and need to be addressed.  SAFE IN COMMON is in a unique to position to advocate for this change. Not only will SAFE IN COMMON serve as a community for those impacted by unsafe needlestick practices and injuries, but it will also act as a unified voice to educate and fight for better, more effective solutions."

Led by a team of highly experienced and influential board members, SAFE IN COMMON was created to raise awareness and support the global transition to safe, simple injections. As a social community, SAFE IN COMMON will also seek to provide support and coverage to all international markets focused on the enhancement of safe injection practices.

Outside of healthcare facilities, SAFE IN COMMON will also seek to address specific injection safety challenges relating to patients who administer prescription drugs at home, injecting drug users and other stakeholders associated with harm reduction, and the vaccination / immunization programs of developing and emerging nations. With such markets that operate largely outside of healthcare facilities, unsafe injection practices such as the re-use, sharing or unsafe disposal of non-sterile injection devices may accelerate HIV and hepatitis C epidemics.

The new website, www.safeincommon.org, will feature blogs, a resource library, links to industry information, forums for contributors to express thoughts and experiences, surveys, and other ways to interact and promote injection safety.

Current SAFE IN COMMON board members include:

  • Mary Foley: RN, MS, PhD, Past President American Nursing Association and Associate Director, Center for Nursing Research and Innovation, University of California, San Francisco.
  • Ron Stoker: Executive Director of the International Sharps Injury Protection Society (ISIPS).
  • Gerald Verollet: Former head of the medical device division at the World Health Organization (WHO).
  • Jason Tetro: Infection control advocate, blogger and coordinator at two research centers for microbiology at the University of Ottawa.
  • Evelyn McKnight: Patient safety advocate, author of "A Never Event" and founder of HONOReform, a national advocacy organization dedicated to protecting patients through safeguarding the medical injection process.

SAFE IN COMMON is also being sponsored by Unilife Corporation (Nasdaq: UNIS), a medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes.

The Community seeks additional alliances with organizations that share in the goal of reducing the global harms of needlestick injuries and other unsafe injection practices. For more information about SAFE IN COMMON, please visit the website at www.safeincommon.org.

About SAFE IN COMMON:

Launched in November 2010, SAFE IN COMMON is a community of healthcare workers, educators, patients, community leaders and individuals who share one desire…a world where every injection is both simple and safe. SAFE IN COMMON features blogs, a resource library, links to industry information, forums for contributors to express thoughts and experiences, surveys, and other ways to interact and promote injection safety. For more information about SAFE IN COMMON, please visit the community's official website at www.safeincommon.org.

Website development by www.trajectory4brands.com.

Media Contact:
Susan Carr
susan.carr@safeincommon.org




'/>"/>
SOURCE SAFE IN COMMON
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board
2. Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010
3. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
4. Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection
5. New Label Changes for Commonly Prescribed HIV Drug Invirase
6. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
7. NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, The Directors Common Fund to Provide Human Tissue for GTEx, the New Genotype-Tissue Expression Project
8. Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock
9. Cannabis Science Issues Guidance on Its Progress Toward FDA Investigative New Drug Applications For Clinical Trials and Proposed Dividend Payout for Current Shareholders to Receive a New Class of Common Stock
10. Regeneron Increases Size of Public Offering of Common Stock
11. Regeneron Pharmaceuticals, Inc. Announces The Sale of 4,500,000 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... OR AKIVA, Israel , February 10, ... Ltd., a leader in the field of cartilage repair, ... on February 5, 2016. The $15 million investment was ... leading Chinese pharmaceutical manufacturer, and was joined by existing ... Financial Holdings and both the Technion Research & Development ...
(Date:2/10/2016)... New York , February 10, 2016 ... Growth, Trends and Forecast 2015 - 2023 ", reveals that ... rather slow growth from 2015 to 2023 owing to patent ... a meager CAGR of 1.30% during the forecast period, the ... to US$38.9 bn in 2023. --> Antibacterial Drugs ...
(Date:2/10/2016)... 2016  Silicon Biosystems Menarini Inc., a developer ... uncover the biological complexities of disease at the ... of innovative technologies for genomics research, today announced ... enabling translational researchers to obtain high-quality sequencing results ... and normal cells in an optimized and seamless ...
Breaking Medicine Technology:
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... medical dynamometers and ergoFET force gauges used in physical therapy, occupational therapy and ... Indicator sensor for resistance cord exercise and therapy, introduces its new microFET Digital ...
(Date:2/11/2016)... , ... February 11, 2016 , ... As part of ... of the Million Dollar Round Table Foundation (MDRTF), has gifted $10,000 to University of ... Colleen’s Dream Foundation President Billy Cundiff. , “We are honored to support a promising ...
(Date:2/10/2016)... ... ... LaserShip, a regional parcel carrier that services the eastern U.S., donated and ... in order to aid in the Flint water crisis. In 2014, LaserShip acquired Prestige ... Clio, only 15 miles away from Flint. , “We have deep roots in the ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting ... Healthcare, recently partnered with Heart City Health Center to improve access ... years, Heart City Health Center has provided the Elkhart community with access to ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is ... leading bottled water brand owners that topped the list as a result of their ... conversion. The premier brand was Tibet 5100, a top notch water company that specializes ...
Breaking Medicine News(10 mins):